Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Propofol for Refractory Migraine
NCT02492295Terminated
- Sponsor
- Einstein Healthcare Network
- Start
- Aug 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of propofol in migraine, sponsored by Einstein Healthcare Network. Primary endpoint: Pain Assessed by Numeric Pain Score. Started Aug 2014; status: terminated.
02
Drugs
propofol
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02492295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02492295.